Skip Header

12 results for author:"Hale G." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (5)

Methods to measure the binding of therapeutic monoclonal antibodies to the human Fc receptor FcgammaRIII (CD16) using real time kinetic analysis and flow cytometry.

Harrison A., Liu Z., Makweche S., Maskell K., Qi H., Hale G.

J Pharm Biomed Anal 63:23-28(2012) · Mapped (5)

Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities.

Ramos J.W., Townsend D.A., Piarulli D., Kolata S., Light K., Hale G., Matzel L.D.

BMC Neurosci 10:134-134(2009) · Mapped (2)

Different glycoforms of the human GPI-anchored antigen CD52 associate differently with lipid microdomains in leukocytes and sperm membranes.

Ermini L., Secciani F., La Sala G.B., Sabatini L., Fineschi D., Hale G., Rosati F.

Biochem. Biophys. Res. Commun. 338:1275-1283(2005) · Mapped (3)

CD52 (CAMPATH1).

Hale G.

J. Biol. Regul. Homeost. Agents 15:386-391(2001) · Mapped (3)

1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.

James L.C., Hale G., Waldmann H., Bloomer A.C., Waldman H.

J. Mol. Biol. 289:293-301(1999) · UniProtKB (1)

Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.

Cheetham G.M., Hale G., Waldmann H., Bloomer A.C.

J. Mol. Biol. 284:85-99(1998) · Mapped (2)

Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis.

Zhou X.Y., van der Spoel A., Rottier R., Hale G., Willemsen R., Berry G.T., Strisciuglio P., Morrone A., Zammarchi E., Andria G. et al.

Hum. Mol. Genet. 5:1977-1987(1996) · UniProtKB (1)

Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.

Xia M.Q., Hale G., Lifely M.R., Ferguson M.A., Campbell D., Packman L., Waldmann H.

Biochem. J. 293:633-640(1993) · UniProtKB (1)

Amino acid sequence around lipoic acid residues in the pyruvate dehydrogenase multienzyme complex of Escherichia coli.

Hale G., Perham R.N.

Biochem. J. 187:905-908(1980) · UniProtKB (1)

The role of lipoic acid residues in the pyruvate dehydrogenase multienzyme complex of Escherichia coli.

Danson M.J., Hale G., Perham R.N.

Biochem. J. 199:505-511(1981) · Mapped (1)

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Davies A., Simmons D.L., Hale G., Harrison R.A., Tighe H., Lachmann P.J., Waldmann H.

J. Exp. Med. 170:637-654(1989) · UniProtKB (1)

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone.

Xia M.-Q., Tone M., Packman L., Hale G., Waldmann H.

Eur. J. Immunol. 21:1677-1684(1991) · UniProtKB (1)

to top of page·

Page 1 of 1